3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-16 12:07 UTC
Treating physicians observed early improvement in a 3-year-old with an aggressive brain tumor receiving investigational intranasal NEO100 through compassionate use in Abu Dhabi. The company said the anecdotal finding is not evidence of safety or efficacy.
News 2026-10-16 12:04 UTC
NeOnc Technologies reported early clinical improvement in its first child treated with investigational NEO100 under compassionate use in Abu Dhabi. The three-year-old boy with an aggressive brain tumor is breathing without ventilator support, according to treating physicians. Physicians also reported emerging leg movem
News 2026-10-16 12:00 UTC
NeOnc reports early clinical improvement in the first child treated with NEO100 under compassionate use in Abu Dhabi.